In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

Positive high-level results in trials of its baxdrostat drug to treat hypertension provided AstaZeneca shares with a ...

Fewer than 10 percent of people with hypertension had their blood sugar under control & fewer than 66 percent of diabetics ...

Researchers found a 30% increased risk of cardiovascular events in patients whose diagnosis was delayed by more than a year ...

Delayed diagnosis of hypertension after initial elevated BP measurement was tied to lower rates of antihypertensive drug ...

The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.

Atrioventricular interval modulation is being studied for patients with uncontrolled hypertension. Could the new technology ...

NIE reveals that Indians consume excessive salt, increasing the risk of hypertension and related diseases. To combat this, ...

High blood pressure rarely shows itself, until it’s done serious harm. But there are signs your body gives you. Catching them ...

The readout is particularly welcome for AZ as baxdrostat (formerly CIN-107) showed mixed results in earlier hypertension ...

Baxdrostat is taken once a day as a pill, and works by targeting a hormone called aldosterone, which plays a key role in ...

AstraZeneca’s $1.3 billion bet on CinCor Pharma and its mid-phase hypertension drug baxdrostat seems to have paid off based ...